Natural products for infectious microbes and diseases: an overview of sources, compounds, and chemical diversities

Abstract

As coronavirus disease 2019 (COVID-19) threatens human health globally, infectious disorders have become one of the most challenging problem for the medical community. Natural products (NP) have been a prolific source of antimicrobial agents with widely divergent structures and a range vast biological activities. A dataset comprising 618 articles, including 646 NP-based compounds from 672 species of natural sources with biological activities against 21 infectious pathogens from five categories, was assembled through manual selection of published articles. These data were used to identify 268 NP-based compounds classified into ten groups, which were used for network pharmacology analysis to capture the most promising lead-compounds such as agelasine D, dicumarol, dihydroartemisinin and pyridomycin. The distribution of maximum Tanimoto scores indicated that compounds which inhibited parasites exhibited low diversity, whereas the chemistries inhibiting bacteria, fungi, and viruses showed more structural diversity. A total of 331 species of medicinal plants with compounds exhibiting antimicrobial activities were selected to classify the family sources. The family Asteraceae possesses various compounds against C. neoformans , the family Anacardiaceae has compounds against Salmonella typhi , the family Cucurbitacea against the human immunodeficiency virus (HIV), and the family Ancistrocladaceae against Plasmodium . This review summarizes currently available data on NP-based antimicrobials against refractory infections to provide information for further discovery of drugs and synthetic strategies for anti-infectious agents. Supporting Information The supporting information is available online at 10.1007/s11427-020-1959-5. The supporting materials are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains entirely with the authors.

Mammea B/BA Isolated From the Seeds of Mammea americana L. (Calophyllaceae) is a Potent Inhibitor of Methicillin-Resistant Staphylococcus aureus

“…Due to the multiple advantages of natural products ( Atanasov et al, 2021 ), modern medicine still depends on them and their molecules for the development of new drugs, being the area of the anti-infectives and anti-cancers where there is a more marked influence ( Newman and Cragg, 2020 ; Luo et al, 2021 ). Natural products remain the main source of antibacterials ( Singh, 2012 ; Harvey et al, 2015 ; Wiese and Imhoff, 2019 ).…”

Antimicrobial activity and molecular docking screening of bioactive components of Antirrhinum majus (snapdragon) aerial parts

“…Herbal medicine constructs the base of today's therapy and medicines, as the plant kingdom provides an infinite source of herbs and plants which can be used as crude drugs or in the form of nutraceuticals (Abdelhalim et al, 2017). The earliest records of employing herbal medicines in managing health issues and microbial infections refer back to the Sumerian, Egyptian, and Chinese civilisations (Süntar, 2020;Luo et al, 2021). Thus, the search for new anti-infectives, especially antimicrobial drugs, is still in demand.…”

SynBioTools: a one-stop facility for searching and selecting synthetic biology tools

“…Here, synthetic biology tools refer to the tools, methods, and databases used for synthetic biology research. All the tools in SynBioTools were extracted from review articles [ 1 , 18 – 53 ] (Additional file 3 ) via SCITE, our custom-built article-table-extraction tool. The method and process of the construction of SynBioTools are summarized in Fig.…”